These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 28823018

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical decision support systems differ in their ability to identify clinically relevant drug interactions of immunosuppressants in kidney transplant patients.
    Amkreutz J, Koch A, Buendgens L, Trautwein C, Eisert A.
    J Clin Pharm Ther; 2017 Jun; 42(3):276-285. PubMed ID: 28224645
    [Abstract] [Full Text] [Related]

  • 3. Analysis of potential drug-drug interactions in medical intensive care unit patients.
    Uijtendaal EV, van Harssel LL, Hugenholtz GW, Kuck EM, Zwart-van Rijkom JE, Cremer OL, Egberts TC.
    Pharmacotherapy; 2014 Mar; 34(3):213-9. PubMed ID: 24390929
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Drug-drug interactions in the intensive care unit: Do they really matter?
    Vanham D, Spinewine A, Hantson P, Wittebole X, Wouters D, Sneyers B.
    J Crit Care; 2017 Apr; 38():97-103. PubMed ID: 27883969
    [Abstract] [Full Text] [Related]

  • 7. Clinically relevant potential drug-drug interactions in intensive care patients: A large retrospective observational multicenter study.
    Bakker T, Abu-Hanna A, Dongelmans DA, Vermeijden WJ, Bosman RJ, de Lange DW, Klopotowska JE, de Keizer NF, SIMPLIFY study group, Hendriks S, Ten Cate J, Schutte PF, van Balen D, Duyvendak M, Karakus A, Sigtermans M, Kuck EM, Hunfeld NGM, van der Sijs H, de Feiter PW, Wils EJ, Spronk PE, van Kan HJM, van der Steen MS, Purmer IM, Bosma BE, Kieft H, van Marum RJ, de Jonge E, Beishuizen A, Movig K, Mulder F, Franssen EJF, van den Bergh WM, Bult W, Hoeksema M, Wesselink E.
    J Crit Care; 2021 Apr; 62():124-130. PubMed ID: 33352505
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prevalence and clinical significance of potential drug-drug interactions among lung transplant patients.
    Zhang J, Ma D, Chen M, Hu Y, Chen X, Chen J, Huang M, Dai H.
    Front Pharmacol; 2024 Apr; 15():1308260. PubMed ID: 38379901
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Frequency and nature of drug-drug interactions in the intensive care unit.
    Askari M, Eslami S, Louws M, Wierenga PC, Dongelmans DA, Kuiper RA, Abu-Hanna A.
    Pharmacoepidemiol Drug Saf; 2013 Apr; 22(4):430-7. PubMed ID: 23420793
    [Abstract] [Full Text] [Related]

  • 13. Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan.
    Ismail M, Iqbal Z, Khattak MB, Khan MI, Arsalan H, Javaid A, Gul Q, Khan F.
    Int J Clin Pharm; 2013 Jun; 35(3):455-62. PubMed ID: 23483444
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Adverse drug events caused by three high-risk drug-drug interactions in patients admitted to intensive care units: A multicentre retrospective observational study.
    Klopotowska JE, Leopold JH, Bakker T, Yasrebi-de Kom I, Engelaer FM, de Jonge E, Haspels-Hogervorst EK, van den Bergh WM, Renes MH, Jong BT, Kieft H, Wieringa A, Hendriks S, Lau C, van Bree SHW, Lammers HJW, Wierenga PC, Bosman RJ, de Jong VM, Slijkhuis M, Franssen EJF, Vermeijden WJ, Masselink J, Purmer IM, Bosma LE, Hoeksema M, Wesselink E, de Lange DW, de Keizer NF, Dongelmans DA, Abu-Hanna A.
    Br J Clin Pharmacol; 2024 Jan; 90(1):164-175. PubMed ID: 37567767
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of potential drug-drug interactions in intensive care unit.
    Dagdelen MS, Gulen D, Ceylan I, Girgin NK.
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5801-5806. PubMed ID: 34604971
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prevalence of drug-drug interactions at hospital entry and during hospital stay of patients in internal medicine.
    Vonbach P, Dubied A, Krähenbühl S, Beer JH.
    Eur J Intern Med; 2008 Oct; 19(6):413-20. PubMed ID: 18848174
    [Abstract] [Full Text] [Related]

  • 20. Potential drug-drug interactions associated with adverse clinical outcomes and abnormal laboratory findings in patients with malaria.
    Noor S, Ismail M, Khadim F.
    Malar J; 2020 Aug 31; 19(1):316. PubMed ID: 32867788
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.